| pubmed-article:11546902 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11546902 | lifeskim:mentions | umls-concept:C0002658 | lld:lifeskim |
| pubmed-article:11546902 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11546902 | lifeskim:mentions | umls-concept:C0003537 | lld:lifeskim |
| pubmed-article:11546902 | lifeskim:mentions | umls-concept:C0599724 | lld:lifeskim |
| pubmed-article:11546902 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:11546902 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:11546902 | pubmed:dateCreated | 2001-9-7 | lld:pubmed |
| pubmed-article:11546902 | pubmed:abstractText | A number of studies suggest that drugs which increase the release of norepinephrine promote recovery when administered late (days to weeks) after brain injury in animals. A small number of clinical studies have investigated the effects of the noradrenergic agonist dextroamphetamine in patients recovering from motor deficits following stroke. To determine whether these findings extend to communication deficits subsequent to stroke, we administered dextroamphetamine, paired with speech/language therapy, to patients with aphasia. | lld:pubmed |
| pubmed-article:11546902 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11546902 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11546902 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11546902 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11546902 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11546902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11546902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11546902 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11546902 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:11546902 | pubmed:issn | 1524-4628 | lld:pubmed |
| pubmed-article:11546902 | pubmed:author | pubmed-author:FordJJ | lld:pubmed |
| pubmed-article:11546902 | pubmed:author | pubmed-author:NatarajanRR | lld:pubmed |
| pubmed-article:11546902 | pubmed:author | pubmed-author:LamFF | lld:pubmed |
| pubmed-article:11546902 | pubmed:author | pubmed-author:CurtinTT | lld:pubmed |
| pubmed-article:11546902 | pubmed:author | pubmed-author:SalmeronEE | lld:pubmed |
| pubmed-article:11546902 | pubmed:author | pubmed-author:UnwinD HDH | lld:pubmed |
| pubmed-article:11546902 | pubmed:author | pubmed-author:Walker-Batson... | lld:pubmed |
| pubmed-article:11546902 | pubmed:author | pubmed-author:DronkersNN | lld:pubmed |
| pubmed-article:11546902 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:11546902 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:11546902 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11546902 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11546902 | pubmed:pagination | 2093-8 | lld:pubmed |
| pubmed-article:11546902 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:meshHeading | pubmed-meshheading:11546902... | lld:pubmed |
| pubmed-article:11546902 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11546902 | pubmed:articleTitle | A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. | lld:pubmed |
| pubmed-article:11546902 | pubmed:affiliation | Stroke Center-Dallas, Department of Communication Sciences & Disorders, Texas Woman's University, The Mobility Foundation Center, Dallas, Texas, USA. DWalkerBatson@twu.edu | lld:pubmed |
| pubmed-article:11546902 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11546902 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11546902 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11546902 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11546902 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11546902 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11546902 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11546902 | lld:pubmed |
